JULY BDI-40 UP 4.5%; ASX200 DOWN 4.0% - YEAR TO JULY 31: BDI-40 UP 74.2%; ASX DOWN 1.5%
August 1st 2011 09:52
Biotech Daily
Monday August 1, 2011
Daily news on ASX-listed biotechnology companies
Monday August 1, 2011
Daily news on ASX-listed biotechnology companies
Subscribe to Biotech Daily at the link above or at www.biotechdaily.com.au
BIOTECH DAILY’S TOP 40 INDEX
Expecting July to be a bad month for biotechnology, following the global trend, it was a surprise to see that the first six companies of the Biotech Daily Top 20 Index (BDI-20) were up.
Thirteen of the BDI-20 improved in July and seven fell, while the Second 20 saw seven rise and seven fall, giving the robust BDI-40 a total of 20 companies up, 14 down and six unchanged.
The Biotech Daily Top 40 Index (BDI-40) was up 4.5 percent for July compared to the S&P ASX200 down 4.0 percent (see charts below). The BDI-40 was up 74.2 percent for the year to July 31, 2011, compared to the ASX200 down 1.5 percent.
The deepest BDI-20 fall of $102 million by Heartware was compensated by Mesoblast’s $129 million (5.3%) increase, but overall the BDI-20 was up $340 million or 5.2 percent.
The three Big Caps of Cochlear, CSL and Resmed (which are not included in the BDI-40) all fell, with CSL the worst, dragging the collective Big Cap total down 5.9 percent for the month and 12.2 percent for the year.
Optiscan was best from a low base, up 62.5 percent to $13 million, followed by the recovering Cathrx up 40 percent to $21 million, Pharmaxis up 30.7 percent to $251 million, Acrux continuing upward by 21.1 percent to $683 million, Bionomics (15.7%), Impedimed (14.6%) and Alchemia (9.95%).
Advanced Surgical led the falls, down 25 percent to $6 million, followed by Sunshine Heart down 23.5 percent to $39 million, Viralytics down 16.3 percent to $36 million, Prana (15.1%) and Heartware (10.3%).
Outside the BDI-40, the post-merger Alllied Health was up 209.1 percent to $34 million, Neuren was up 66.7 percent to $15 million, while Reva fell 22 percent to $238 million.
Biotechs raised $24.4 million in July.
BDI-40 v ASX200 Jul 31, 2010 to Jul 31, 2011
BDI-40 v ASX200 Jun 30, 2006 to Jul 31, 2011
Subscribe to Biotech Daily at the link above or at www.biotechdaily.com.au
| 14 |
| Vote |
Add To: 
subscribe to this blog